Lis, A.; Lis, P.; Łowicka, W.; Grabarczyk, M.; Wita, M.; Żarczyński, P.; Żarczyńska, M.; Haberka, M.
Lipid-Lowering Treatment and the Lipid Goals Attainment in Patients with a Very High Cardiovascular Risk. J. Cardiovasc. Dev. Dis. 2023, 10, 329.
https://doi.org/10.3390/jcdd10080329
AMA Style
Lis A, Lis P, Łowicka W, Grabarczyk M, Wita M, Żarczyński P, Żarczyńska M, Haberka M.
Lipid-Lowering Treatment and the Lipid Goals Attainment in Patients with a Very High Cardiovascular Risk. Journal of Cardiovascular Development and Disease. 2023; 10(8):329.
https://doi.org/10.3390/jcdd10080329
Chicago/Turabian Style
Lis, Anna, Paulina Lis, Weronika Łowicka, Małgorzata Grabarczyk, Michał Wita, Piotr Żarczyński, Małgorzata Żarczyńska, and Maciej Haberka.
2023. "Lipid-Lowering Treatment and the Lipid Goals Attainment in Patients with a Very High Cardiovascular Risk" Journal of Cardiovascular Development and Disease 10, no. 8: 329.
https://doi.org/10.3390/jcdd10080329
APA Style
Lis, A., Lis, P., Łowicka, W., Grabarczyk, M., Wita, M., Żarczyński, P., Żarczyńska, M., & Haberka, M.
(2023). Lipid-Lowering Treatment and the Lipid Goals Attainment in Patients with a Very High Cardiovascular Risk. Journal of Cardiovascular Development and Disease, 10(8), 329.
https://doi.org/10.3390/jcdd10080329
